27.1 C
Vientiane
Wednesday, July 2, 2025
spot_img
Home Blog Page 1046

Tuya to Release Smart Door Lock Solution with Matter and Home Key in Apple Wallet Support

NEW YORK, Jan. 21, 2025 /PRNewswire/ —Tuya Smart (NYSE: TUYA, HKEX: 2391), the global cloud platform service provider today introduced a new smart door lock solution that supports both the Matter protocol and home key in Apple Wallet. This allows users to seamlessly and securely add a home key to Apple Wallet to access and unlock their homes with a simple tap of an iPhone or Apple Watch.

Users can add their home key to Apple Wallet after an initial set up. The setup process is straightforward:

– First, after installing the smart door lock, the user should put the device into pairing mode.
– Next, open the Home app and scan the Matter QR code on the door lock to add it to the app.
– Once added, a “virtual home key” will instantly appear in the user’s Apple Wallet.
– Finally, users can set a PIN code within the Home App, enabling them to unlock the door using the PIN code.
– They can hold their iPhone or Apple Watch near a smart lock for convenient access.

With Express Mode, users don’t need to wake or unlock their device to use their home key—they can simply hold their device near a reader.

By leveraging Tuya’s Solution for Matter, this smart door lock seamlessly integrates with Apple Home. iPhone, iPad, and Mac users can easily manage the door lock using the Apple Home App.

Home key in Apple Wallet takes full advantage of the privacy and security features already built into iPhone and Apple Watch. Data is encrypted and protected against tampering and theft, and Apple cannot see when and where a user uses a home key in Wallet.

At CES 2025, this smart door lock solution captivated attendees, sparking widespread curiosity and drawing crowds who were eager to explore its innovative design and seamless integration of Tuya’s solutions. In addition to NFC access, the product supports multiple unlocking methods, including palm vein recognition, password entry, and app based unlocking, ensuring a smooth and versatile door-opening experience for users across various scenarios.

As an early adopter and advocate of the Matter protocol, Tuya remains steadfast in its mission to advance the global implementation of Matter-enabled smart devices. Supporting home key in Apple Wallet represents a significant milestone in Tuya’s broader strategy to align Matter product solutions with other leading ecosystems. To date, Tuya has earned over 200 Matter certifications, spanning five major categories: electrical devices, lighting, gateways, sensors, and home appliances. These certifications cover an array of smart home products, including light bulbs, LED strips, switches, gateways, sockets, sensors, curtains, and thermostats, showcasing Tuya’s comprehensive capabilities in the smart home domain.

Ascletis Announces Positive Results from U.S. Phase Ia Single Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Provides Program Update

  • ASC30 oral tablet demonstrated dose-proportional pharmacokinetic (PK) properties and a long half-life (t1/2) up to 60 hours in the single ascending dose (SAD) study of patients with obesity, supporting once-daily or less frequent oral dosing.
  • ASC30 oral tablet was generally safe and well tolerated. All adverse events (AEs) were mild (grade 1) or moderate (grade 2), and most of the AEs were gastrointestinal (GI)-related. There were no grade 3 or higher AEs as well as no serious AEs (SAEs). Alanine aminotransferase (ALT), aspartate aminotransferase (AST), and other liver enzymes were in normal ranges.
  • ASC30 oral tablet is stable at room temperature. Relative oral bioavailability of ASC30 tablet is 99% in animal models.
  • Data from the animal models utilizing a new tablet formulation of ASC30 support up to once-weekly oral dosing.
  • Topline results, including weight loss, safety and PK, from the U.S. Phase Ib multiple ascending dose (MAD) study of ASC30 oral tablet, once daily, in obese patients are expected by the end of March 2025.

HONG KONG, Jan. 21, 2025 /PRNewswire/ — Ascletis Pharma Inc. (HKEX:1672, “Ascletis”) announces today positive topline results from its U.S. single ascending dose (SAD) study  (NCT06680440) of ASC30 oral tablet in patients with obesity (body mass index (BMI): 30-40 kg/m2). The SAD study consists of five cohorts (2 mg, 5 mg, 10 mg, 20 mg and 40 mg) with a total of 40 patients with obesity under fasting conditions.

ASC30 oral tablet demonstrated dose-proportional pharmacokinetic (PK) properties and a long half-life (t1/2) up to 60 hours in the SAD study of patients with obesity, supporting once-daily or less frequent oral dosing. Cross-trial comparison indicates that in humans, drug exposure (area under the curve, “AUC”) of 5 mg ASC30 single dose is 2.2-fold of that of 6 mg orforglipron single dose [1]. ASC30 oral tablet demonstrated superior PK properties (including a longer t1/2 and higher AUC) to other small molecule oral GLP-1 receptor (GLP-1R) agonists in development [1-3], suggesting ASC30 oral tablet has the potential to be a best-in-class small molecule GLP-1R agonist to treat obesity.

In Cohort 5, 40 mg ASC30 oral tablet single dose was given orally to patients with obesity under both fasting and fed conditions. The data indicated that ASC30 oral tablet’s PK properties including AUC and t1/2 were essentially identical in the absence or presence of food, suggesting that ASC30 oral tablet can offer patient-friendly, once-daily oral dosing without food and water restrictions.

ASC30 oral tablet was generally safe and well tolerated in the Phase Ia SAD study.  All adverse events (AEs) were mild (grade 1) or moderate (grade 2), and most of the AEs were gastrointestinal (GI)-related. There were no grade 3 or higher AEs, as well as no serious AEs (SAEs). GI-related safety profiles of ASC30 oral tablet were consistent with or better than other small molecule oral GLP-1R agonists in development [1, 3, 4] (Table 1). Furthermore, alanine aminotransferase (ALT), aspartate aminotransferase (AST), and other liver enzymes were in normal ranges.

Table 1. All GI-related AEs of ASC30 oral tablet were mild (grade 1) or moderate (grade 2)

TEAE, n (%)

Placebo
(N = 10)

Cohort 1
2 mg ASC30
(N=6)

Cohort 2
5 mg ASC30
(N=6)

Cohort 3
10 mg ASC30
(N=6)

Cohort 4
20 mg ASC30
(N=6)

Cohort 5
40 mg ASC30
(N=6)

GI-related TEAE

1 (10.0)

0

1 (16.7)

4 (66.7)

5 (83.3)

6 (100.0)

Diarrhea

0

0

1 (16.7)

0

0

0

Constipation

1 (10.0)

0

0

0

1 (16.7)

1 (16.7)

Vomiting

0

0

0

2 (33.3)

5 (83.3)

5 (83.3)

Nausea

1 (10.0)

0

1 (16.7)

3 (50.0)

5 (83.3)

6 (100.0)

TEAE: Treatment-Emergent Adverse Event; GI: Gastrointestinal; n: Number of patients who had GI-related TEAE in
each dose level; N: Number of patients who received the study drug.

ASC30 oral tablet formulation, which is stable at room temperature, was developed using Ascletis’ proprietary technology and has a relative oral bioavailability of 99% at steady state in animal models. Data from the animal models utilizing a new tablet formulation (stable at room temperature) of ASC30 support up to once-weekly oral dosing.

ASC30 was discovered and developed in-house at Ascletis as a GLP-1R biased small molecule agonist without β-arrestin recruitment.  ASC30 has unique and differentiated properties that enable the administration of one small molecule as both a once-monthly subcutaneous injection and a once-daily oral tablet. ASC30 has two- to three-fold better in vitro potency against GLP-1R when compared head-to-head with orforglipron. In the intravenous glucose tolerant test (IVGTT) in non-human primates (NHPs), ASC30 (1.5 mg/kg dose) stimulated statistically and significantly more insulin secretion when compared head-to-head with orforglipron (6 mg/kg dose).

ASC30 is the first and only small molecule GLP-1R biased agonist that can be dosed once monthly subcutaneously and once daily orally for the treatment of obesity. ASC30 oral tablet has the potential to be a best-in-class GLP-1R small molecule agonist given its PK and safety profiles as well as potency against GLP-1R.

“We are excited that the results from our Phase Ia SAD trial of ASC30 oral tablet, once daily in patients with obesity demonstrated potential best-in-class characteristics. With superior PK properties observed in the SAD study, we are looking forward to sharing efficacy, safety, and PK data from Phase Ib 28-day multiple ascending dose (MAD) trial of patients with obesity by the end of March this year,” said Dr. Jinzi Jason Wu, Founder, Chairman and CEO of Ascletis, “As one small molecule, ASC30 potentially offers both once-daily oral and once-monthly subcutaneous injection dosing options.”

ASC30 Oral Tablet U.S. Phase Ib MAD Study Update

The ASC30 oral tablet MAD study consists of 3 cohorts with weekly titrations in which patients with obesity are treated for 28 days with ASC30 oral tablet once daily or placebo. Cohort 1 (2 mg, 5 mg, 10 mg and 20 mg) has been completed. Cohort 2 (2 mg, 10 mg, 20 mg and 40 mg) and Cohort 3 (5 mg, 15 mg, 30 mg and 60 mg) are expected to be completed in late February and March 2025, respectively. Topline results from the MAD study, including weight loss, safety and PK, are expected by the end of March 2025.

ASC30 Oral Tablet U.S. Phase Ia and Ib Clinical Studies for the Treatment of Obesity

The Phase Ia study of ASC30 oral tablet once-daily is a randomized, double-blind, placebo-controlled, single ascending dose (5 cohorts) study to evaluate the safety, tolerability, and PK of ASC30 oral tablet in patients with obesity (BMI: 30-40 kg/m2).

The Phase Ib study of ASC30 oral tablet once daily is a randomized, double-blind, placebo-controlled, multiple ascending dose (3 cohorts, weekly titration, once-daily treatment for 28 days) study to evaluate the safety, tolerability, PK and efficacy of ASC30 in patients with obesity (BMI: 30-40 kg/m2).

About ASC30

ASC30 is an investigational GLP-1R biased small molecule agonist and has unique and differentiated properties that enable the same small molecule for both subcutaneous injection and oral tablet administrations. ASC30 is a new molecular entity (NME), with U.S. and global compound patent protection until 2044.

References

  1. Diabetes Obes Metab. 2023; 25:2634–2641.
  2. Obesity 2024: Volume 32, Issue S1, Poster 342.
  3. Obesity 2024: Volume 32, Issue S1, Poster 219.
  4. Diabetes 2023: Volume 72, Issue Supplement_1, Poster 754.

About Ascletis Pharma Inc.

Ascletis is an innovative R&D driven biotech listed on the Hong Kong Stock Exchange (1672.HK), covering the entire value chain from discovery and development to GMP manufacturing. Led by a management team with deep expertise and a proven track record, Ascletis is focused on two therapeutic areas with unmet medical needs from a global perspective: metabolic diseases and viral diseases. Ascletis has multiple clinical stage drug candidates in its R&D pipeline.

For more information, please visit www.ascletis.com.

Contact:
Peter Vozzo
ICR Healthcare
443-231-0505 (U.S.)
Peter.vozzo@icrhealthcare.com

Ascletis Pharma Inc. PR and IR teams
+86-181-0650-9129 (China)
pr@ascletis.com
ir@ascletis.com

ChipMOS ANNOUNCES NT$350 MILLION SHARE REPURCHASE PROGRAM

HSINCHU, Jan. 21, 2025 /PRNewswire-FirstCall/ — ChipMOS TECHNOLOGIES INC. (“ChipMOS” or the “Company”) (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS), an industry leading provider of outsourced semiconductor assembly and test services (“OSAT”), today announced that its Board of Directors has authorized a share repurchase program with the total amount up to NT$350 million (approximately US$10.7 million, based on the exchange rate of NT$32.79 to US$1.00 as of December 31, 2024).

Under the program, the company will repurchase up to 10,000,000 shares from the open market on the Taiwan Stock Exchange, representing approximately 1.38% of its issued share capital. The shares will be repurchased within a price range of NT$21.18 to NT$35.00 per share, while the buyback will still be carried out if the stock price falls lower than the aforementioned range. The authorization repurchase program period is from January 22 to March 21, 2025.

S.J. Cheng, Chairman and President of ChipMOS, said, “Our latest repurchase authorization is inline with our capital allocation strategy and directly reflects our view that our shares are undervalued and represent a highly compelling investment opportunity. We remain confident in our financial performance, and focused on the strategic initiatives that will help drive our continued growth and leadership success, as we work to build long-term shareholder value.”

About ChipMOS TECHNOLOGIES INC.:

ChipMOS TECHNOLOGIES INC. (“ChipMOS” or the “Company”) (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS) (www.chipmos.com) is an industry leading provider of outsourced semiconductor assembly and test services. With advanced facilities in Hsinchu Science Park, Hsinchu Industrial Park and Southern Taiwan Science Park in Taiwan, ChipMOS is known for its track record of excellence and history of innovation. The Company provides end-to-end assembly and test services to leading fabless semiconductor companies, integrated device manufacturers and independent semiconductor foundries serving virtually all end markets worldwide.

Forward-Looking Statements:

This press release may contain certain forward-looking statements. These forward-looking statements may be identified by words such as ‘believes,’ ‘expects,’ ‘anticipates,’ ‘projects,’ ‘intends,’ ‘should,’ ‘seeks,’ ‘estimates,’ ‘future’ or similar expressions or by discussion of, among other things, strategies, goals, plans or intentions. These statements may include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives and expectations with respect to future operations, products and services, and statements regarding future performance. Actual results may differ materially in the future from those reflected in forward-looking statements contained in this document, due to various factors. Further information regarding these risks, uncertainties and other factors are included in the Company’s most recent Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (the “SEC”) and in the Company’s other filings with the SEC.

Contacts:

In Taiwan

Jesse Huang

ChipMOS TECHNOLOGIES INC.

+886-6-5052388 ext. 7715

IR@chipmos.com

In the U.S.

David Pasquale

Global IR Partners

+1-914-337-8801

dpasquale@globalirpartners.com

Be My Guest: The Culture Episode

GUIYANG, China, Jan. 21, 2025 /PRNewswire/ — Southwestern China’s Guizhou, often called the “Land of a Thousand Cultures,” is a province of highland and mountains. As a Chinese saying goes, in Guizhou, “Every mountain is home to an ethnic group, customs differ every ten miles, and traditions differ every hundred miles.” The province is rich in cultural diversity, showcasing its unique charm and vitality among other regions in China.


Be My Guest: The Culture Episode

The short video series”Be My Guest • Focus Guizhou“, produced by Guizhou Satellite TV and the International Communication Center of Guizhou Radio and Television Station, is a documentary about the real life of local people from the perspectives of international photographers who come to explore Guizhou.

In this episode, American photographer Dan Sandoval comes along with Chen Jing, a student in the Department of Drama and Performance at Guizhou University, to take a journey in Guizhou and experience the region’s beautiful landscape and vibrant culture.

Dan and Chen meet in Anshun city, where they delve into the 600-year-old Tunpu culture. This culture can be dated back to the Ming Dynasty when the imperial court moved part of troops and immigrants from northern China to Anshun. After the war ended, the stationed troops settled down and thereafter lived for generations. The settlers’ old customs became a legacy that is still preserved today. Through watching Anshun Dixi Opera, Dan and Chen feel the thrilling war years of the ancient settlers.

Next, they visit the Guizhou Peking Opera Theatre to watch Yangming‘s Enlightenment, a drama performance that tells the story of Wang Yangming, a renowned philosopher, educator, and military strategist in the Ming Dynasty.

Finally, they travel to Congjiang County, where they marvel at the picturesque village scenery and experience the charm of ethnic traditions. In Biasha Miao Village, they are captivated by the Miao culture of “the tree of life”, and in Gaozeng Dong village, they are enchanted by the Grand Songs of the Dong people. This ancient form of multi-part, unaccompanied choral singing has been practiced for over 2,500 years. In 2009, it was inscribed on the list of the UNESCO Intangible Cultural Heritage of Humanity.

“I’m already planning my next trip to Guizhou!” Dan says, who is deeply moved by the vibrant culture and unforgettable experience. He’s eager to return with his camera to explore more places and landscapes and immerse himself once again in the region’s culture.

https://youtu.be/3ChKzNWkGvs

Synechron Earns Great Place to Work Certification™ in 14 Countries

SYDNEY, Jan. 21, 2025 /PRNewswire/ — Synechron, Inc., a leading global digital transformation consulting firm, has been officially accredited as a Great Place to Work® Certified™ organization for 2024 to 2025 in 14 countries. This recognition is based on anonymous feedback from more than 14,500 Synechron employees collected through Great Place To Work®.

Synechron was certified in the following countries:

  • Australia
  • Bulgaria
  • Canada
  • France
  • India
  • Japan
  • Luxembourg
  • Mexico
  • Serbia
  • Singapore
  • Switzerland
  • United Arab Emirates
  • United Kingdom
  • United States of America

“With this global recognition, we reaffirm our commitment to fostering an inclusive, collaborative workplace where employees can thrive,” said Faisal Husain, Synechron’s co-founder and CEO. “Our people are at the heart of what we do, driving innovation and delivering transformative solutions for our clients.”

The Great Place To Work® Trust Index™ Survey provides valuable insights into the organization’s performance by assessing five key areas: Credibility, respect, fairness, pride, and camaraderie. These pillars reflect a positive employee experience and highlight the level of trust that employees have in the organization.

“A Great Place To Work® Certification is a highly coveted achievement that requires consistent and intentional dedication to the overall employee experience,” says Sarah Lewis-Kulin, the vice president of global recognition at Great Place To Work®. “By successfully earning this recognition, it’s evident that Synechron stands out as one of the top companies to work for, providing an excellent workplace environment for its employees.”

About Synechron:

At Synechron, we believe in the power of digital to transform businesses for the better. Our global consulting firm combines creativity and innovative technology to deliver industry-leading digital solutions. Synechron’s progressive technologies and optimization strategies span end-to-end Artificial Intelligence, Consulting, Digital, Cloud & DevOps, Data, and Software Engineering, servicing an array of noteworthy financial services and technology firms. Through research and development initiatives in our FinLabs we develop solutions for modernization, from Artificial Intelligence and Blockchain to Data Science models, Digital, cloud-native, mobile-first applications and more. Over the last 20+ years, our company has been honored with multiple employer awards, recognizing our commitment to our talented teams. With top clients to boast about, Synechron has a global workforce of 14,500+, and has 58 offices in 21 countries within key global markets. For more information on the company, please visit our website or LinkedIn community.

About Great Place To Work®

Great Place To Work® is the global authority on workplace culture. Our mission is to help every place become a great place to work for all. We give leaders and organizations the recognition and tools to create a consistently and overwhelmingly positive employee experience, fostering cultures that are proven to drive business, improve lives, and better society. Our recognition is the most coveted and respected in the world for elevating employer brands to attract the right people. Our proprietary methodology and platform enables organizations to truly capture, analyze, and understand the experience of all employees. Our groundbreaking research empowers organizations to build cultures that retain talent and unlock the potential of every employee. Our coaches, content, and community connect the boldest leaders, ideas, and innovations in employee experience. Since 1992, our Certification™, Best Workplaces™ Lists, and global benchmarks have become the industry standard, built on data from more than 100 million employees in 150 countries around the world. For more information, visit www.greatplacetowork.com.

For more information please contact:

Randall Jensen
Head of Communications & PR
Synechron
(+1) 7329438076
randall.jensen@synechron.com

Or

Rashmi Joshi
Media Relations, Synechron
(+91) 9560694654
Rashmi.Joshi@synechron.com

 

IFEZ captivates global audience with its innovative companies at CES 2025

  • IFEZ’s ‘INCHEON-IFEZ’ Booth attracts 12,000 visitors
  • Participating companies secure a foundation for global expansion, including 10 MoU signings

INCHEON, South Korea, Jan. 21, 2025 /PRNewswire/ — The Incheon Free Economic Zone Authority (IFEZ) has announced that the ‘INCHEON-IFEZ’ booth at CES 2025 showcased its vision for the future of smart cities and promoted innovative companies from Incheon to a global audience.

IFEZ captivates global audience with its innovative companies at CES 2025
IFEZ captivates global audience with its innovative companies at CES 2025

CES 2025 (Consumer Electronics Show 2025), the largest technology exhibition in the world, took place in Las Vegas, USA, from Tuesday, January 7, to Friday, January 10th.

The INCHEON-IFEZ Booth, themed “Urban Renaissance: Building Tomorrow’s Smart Cities Today,” garnered attention by demonstrating a sustainable urban future powered by advanced technologies from Incheon-based companies. During the event, the booth welcomed more than 12,000 visitors.

To boost the global presence of Incheon’s startups, IFEZ supported the participation of 41 companies at CES 2025, dividing them across various exhibition areas: 10 companies in the ‘INCHEON-IFEZ’ Booth at the Las Vegas Convention Center, 10 in the Korea pavilion (KOTRA) at the Eureka Park, 6 in the Global Pavilion, and 15 as the Incheon Startup Park Delegation.

These companies achieved record-breaking results, conducting 869 export consultations with international buyers and investors, which amounts to an estimated $400 million in potential deals.

Notably, Sheco, a company specializing in robotic solutions for recovering oil spills, was highlighted as one of the “12 Must-See Startups at CES 2025” by The Vertical, a U.S. media outlet covering tech startups, underscoring the company’s innovative capabilities.

Six companies signed 10 Memorandums of Understanding (MOUs) for tangible outcomes, creating opportunities for global market expansion and attracting investments.

Additionally, 12 companies supported by IFEZ won 13 CES Innovation Awards, setting a new record. The award-winning companies attracted significant interest from global buyers and investors, firmly establishing their innovation and technological prowess on the world stage.

At CES 2025, IFEZ actively promoted its initiatives and innovative companies through various programs. On the first day of the exhibition, the ‘Unveiled Incheon Media Stage’ was held for about 30 global media outlets. This event highlighted IFEZ’s commitments to supporting businesses with world-class infrastructure and fostering global cooperation centered on its thriving innovation ecosystem.

Also, “All Connected Incheon Night,” held on the evening of January 7 (local time), brought together distinguished global leaders, including Kate Gallego, Mayor of Phoenix; Victor Hoskins, CEO of Fairfax County Economic Development Authority; and Doug Bruhnke, CEO of Global Chamber.

IFEZ signed a Memorandum of Understanding (MoU) with Global Chamber, a global business network organization during the gathering. This collaboration aims to strengthen the partnership and better support startups in expanding worldwide.

Commissioner Yun Wonsok said, “Through this participation in CES, we have showcased IFEZ’s smart city vision to the global market and taken a step closer to our goal of becoming a ‘Global Top 10 City, Incheon.'” He emphasized, “We will continue to support IFEZ and Incheon startups in leading the global market and do our utmost to develop Incheon into a global business hub.

Infosys leads the industry with the fastest growing CAGR in brand value of 18% over 5 years. Maintains leadership as a global Top 3 IT services brand

Infosys CEO Salil Parekh is the No.1 IT services CEO, for the second year in a row, in the Brand Guardianship Index 2025

DAVOS, Switzerland, Jan. 21, 2025 /PRNewswire/ — Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced that Brand Finance, the world’s leading brand valuation firm, has recognized the company as a Top 3 IT services brand and the fastest growing IT services brand globally, with a CAGR of 18% over 5 years in its Brand Finance Global 500 2025 report. Infosys’ brand value has grown to over US$16 billion in 2025, and Infosys is ranked as #132 most valuable brand in the world.

Infosys Chief Executive Officer, Salil Parekh, for the second year in a row, tops the IT services ranking in Brand Finance’s Brand Guardianship Index (BGI) 2025 for the role of CEO as brand custodian and steward of long-term shareholder value.

“Over the last four decades, brand Infosys has been nurtured by our founders and our leadership, carefully balancing purpose, promise and performance. This relentless focus is reflected in the brand’s leadership and steady gains in brand value over the years,” said Sumit Virmani, Global Chief Marketing Officer, Infosys. “We are delighted with Brand Finance’s recognition of Infosys’ continued brand momentum and differentiated value creation for businesses in an AI-first world,” he added.

Brand Finance has positioned Infosys among the world’s top 3 most valuable IT services brands for the fourth consecutive year. This is a testament to Infosys’ deep relevance and leadership in a world where companies are looking to digital and enterprise AI solutions to solve tough business challenges. Infosys has earned a brand reputation for tackling critical IT challenges, while upholding ethical standards, fostering trust and inclusion. This is enabled through continued investments in sub-brands like Infosys Topaz – its generative AI-powered solutions and Infosys Cobalt – the industry’s first ever cloud services brand.

David Haigh, CEO and Chairman at Brand Finance, commented, “Infosys has demonstrated remarkable growth over the past five years, achieving the fastest CAGR among IT services brands. The company has strategically prioritized innovation and emerging technologies, with a strong focus on generative AI. Infosys has also consistently leveraged high-profile sponsorships and strategic partnerships, intensifying its brand visibility and market presence in recent years. This commitment to technological innovation and strategic brand positioning has not only enhanced Infosys’ brand value growth but has also strengthened its brand on the global stage, reflected in an enhanced brand strength score and an impressive AAA rating.”

Even as brand Infosys has evolved to remain relevant to the shifting needs of stakeholders and to help them navigate their next, it remains unchanging in its commitment to live its purpose – amplifying human potential and creating the next opportunity for all. With the work of Infosys Foundation, the brand continues to create positive impact in healthcare, education, sustainability, and women empowerment. The Infosys Springboard initiative helps build digital skills by providing free learning programs to 12 million people around the world. As an environmentally conscious global enterprise, Infosys continues to be carbon neutral. The brand was recognized by Ethisphere, once again, in 2024, among the world’s most ethical companies.

About Infosys

Infosys is a global leader in next-generation digital services and consulting. Over 300,000 of our people work to amplify human potential and create the next opportunity for people, businesses and communities. We enable clients in more than 56 countries to navigate their digital transformation. With over four decades of experience in managing the systems and workings of global enterprises, we expertly steer clients, as they navigate their digital transformation powered by cloud and AI. We enable them with an AI-first core, empower the business with agile digital at scale and drive continuous improvement with always-on learning through the transfer of digital skills, expertise, and ideas from our innovation ecosystem. We are deeply committed to being a well-governed, environmentally sustainable organization where diverse talent thrives in an inclusive workplace.

Visit www.infosys.com to see how Infosys (NSE, BSE, NYSE: INFY) can help your enterprise navigate your next.

Safe Harbor

Certain statements in this release concerning our future growth prospects, or our future financial or operating performance, are forward-looking statements intended to qualify for the ‘safe harbor’ under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results or outcomes to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the execution of our business strategy, increased competition for talent, our ability to attract and retain personnel, increase in wages, investments to reskill our employees, our ability to effectively implement a hybrid work model, economic uncertainties and geo-political situations, technological disruptions and innovations such as Generative AI, the complex and evolving regulatory landscape including immigration regulation changes, our ESG vision, our capital allocation policy and expectations concerning our market position, future operations, margins, profitability, liquidity, capital resources, our corporate actions including acquisitions, and cybersecurity matters. Important factors that may cause actual results or outcomes to differ from those implied by the forward-looking statements are discussed in more detail in our US Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2024. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in the Company’s filings with the Securities and Exchange Commission and our reports to shareholders. The Company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Company unless it is required by law.

 

THE MARKETING SOCIETY ANNOUNCES NEW LEADERSHIP FOR SINGAPORE HUB

SINGAPORE, Jan. 21, 2025 /PRNewswire/ — The Marketing Society proudly announces key leadership updates within its Singapore hub as the organisation continues to strengthen its commitment to empower marketers to thrive and lead, raising marketing’s positive impact across the Asia-Pacific region.

Gita De Beer, Global Director of Strategic Initiatives at Heineken, takes on the role of its new Chair in Singapore alongside six new board members. This significant step in the Society’s growth in Asia brings together senior leaders from world-class brands, united in their mission to drive marketing excellence across the region. Gita brings over 18 years of experience with iconic brands such as Unilever, Coca-Cola, and Diageo. Having previously served as a board member, she now takes the helm of the Singapore Hub. As the new Chair of The Marketing Society Singapore, Gita is deeply committed to elevating the work of Asian marketers onto the global stage while fostering their personal growth. Her vision is to empower marketers in Singapore and the region to lead with confidence, realise their ambitions and amplify Asia’s unique strengths worldwide.

Speaking on her new appointment as Singapore Chair, De Beer said: “At The Marketing Society Singapore, you, our Members, are the reason we exist. We are dedicated to empowering marketers at every stage of their careers to thrive, connect, and lead with confidence. I am incredibly proud to introduce our exceptional new board of senior leaders—trailblazers behind some of the world’s most iconic brands. These aren’t just industry leaders, they’re changemakers whose experience spans building brands from within, navigating growth, and leading through transformation. Together, as a board, we are committed to supporting you in unlocking your full potential as we navigate the exciting challenges and opportunities ahead. Let’s connect, grow, and lead together.”

In addition to this leadership change, The Marketing Society is delighted to welcome six newly appointed board members:

  • Amrita Randhawa, CEO, Singapore & Southeast Asia, Publicis Groupe
  • Cindy Tan, Managing Director, Global Clients APAC, Meta
  • Lex Bradshaw-Zanger, Chief Marketing & Digital Officer SAPMENA, L’Oréal Groupe
  • Severine Vauleon, Global Brand Vice President, Unilever (Lux)
  • Siew Ting Foo, Transformational Growth Leader and Author (ex HP/Diageo/Mars/Unilever)
  • Sohil Tiwari, Chief Financial Officer APAC, ex Mastercard

These leaders bring unparalleled expertise and a shared commitment to innovation, inclusivity, and excellence and they join existing board members; Erica Kerner, MD, Global Head of Brand Partnerships, Sponsorships & Events, Standard Chartered, Lynette Pang, Deputy CEO, National Arts Council, Matthias Blume, VP & General Manager Alcoholic Ready to Drink Beverages ASEAN & South Pacific Coca-Cola, Xiaowei Liu, Director, Special Projects, Asia World Energy Council. Together, they will create new opportunities for marketers to thrive, ensuring that The Marketing Society continues to be a driving force for transformation and growth.

Sophie Devonshire, CEO of The Marketing Society, said, “Gita’s dynamic leadership and the expertise of our new board members will help us continue to build our growth and success in Singapore. Their combined experience across global brands and markets is superb in helping support the best, most ambitious marketing leaders across Southeast Asia.”

About The Marketing Society
www.marketingsociety.com

The Marketing Society is a leading global community of the world’s smartest marketers raising the quality and importance of our profession and our impact on business, the economy and in society.

We strive to inspire, accelerate, and unite the marketing leaders of today and tomorrow to help them do well in their careers and do good in their organisations and society, championing marketing excellence and empowering brave leadership.

We work together to grow marketing’s positive impact because we believe that brilliant marketers and brave leaders grow organisations and change the world. We connect the changemakers, those who want to make an impact and make a difference because we know that together, as a community, we achieve more than we do alone.

We were founded in 1959 as a not-for-profit membership organisation. Since then, we have grown to become a highly influential global community of marketing leaders with bases including England, Scotland, Hong Kong, Singapore, United Arab Emirates and New York.

Through the connections of our 2800+ membership community, a world-class programme of events, ground-breaking professional development programmes, prestigious award programmes, publications and insightful content, we help empower our members to lead success in their organisations and add value to customers and society, leading the conversation in businesses and the industry.

Top left to right: Gita De Beer, Global Director of Strategic Initiatives at Heineken; Amrita Randhawa, CEO, Singapore & Southeast Asia, Publicis Groupe; Cindy Tan, Managing Director, Global Clients APAC, Meta; Lex Bradshaw-Zanger, Chief Marketing & Digital Officer SAPMENA, L'Oréal Groupe.   Middle left to right: Severine Vauleon, Global Brand Vice President, Unilever (Lux); Siew Ting Foo, Transformational Growth Leader and Author (ex HP/Diageo/Mars/Unilever); Sohil Tiwari, Chief Financial Officer APAC, ex Mastercard; Erica Kerner, MD, Global Head of Sponsorship & Events, Standard Chartered Bank.   Bottom left to right: Lynette Pang, Deputy Chief Executive Officer, National Arts Council; Matthias Blume, VP of Marketing ASEAN and South Pacific, The Coca-Cola Company; Xiaowei Liu, Asia Director, World Energy Council.   Individual images available upon request.
Top left to right: Gita De Beer, Global Director of Strategic Initiatives at Heineken; Amrita Randhawa, CEO, Singapore & Southeast Asia, Publicis Groupe; Cindy Tan, Managing Director, Global Clients APAC, Meta; Lex Bradshaw-Zanger, Chief Marketing & Digital Officer SAPMENA, L’Oréal Groupe. Middle left to right: Severine Vauleon, Global Brand Vice President, Unilever (Lux); Siew Ting Foo, Transformational Growth Leader and Author (ex HP/Diageo/Mars/Unilever); Sohil Tiwari, Chief Financial Officer APAC, ex Mastercard; Erica Kerner, MD, Global Head of Sponsorship & Events, Standard Chartered Bank. Bottom left to right: Lynette Pang, Deputy Chief Executive Officer, National Arts Council; Matthias Blume, VP of Marketing ASEAN and South Pacific, The Coca-Cola Company; Xiaowei Liu, Asia Director, World Energy Council. Individual images available upon request.